O'Neil, B. H., Scott, A. J., Ma, W. W., Cohen, S. J., Aisner, D. L., Menter, A. R., . . . Messersmith, W. A. (2015). A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer(†). Ann Oncol.
Παραπομπή Chicago StyleO'Neil, B. H., et al. "A Phase II/III Randomized Study to Compare the Efficacy and Safety of Rigosertib Plus Gemcitabine Versus Gemcitabine Alone in Patients With Previously Untreated Metastatic Pancreatic Cancer(†)." Ann Oncol 2015.
Παραπομπή MLAO'Neil, B. H., et al. "A Phase II/III Randomized Study to Compare the Efficacy and Safety of Rigosertib Plus Gemcitabine Versus Gemcitabine Alone in Patients With Previously Untreated Metastatic Pancreatic Cancer(†)." Ann Oncol 2015.